- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Docetaxel
Total 2239 results
-
UNICANCERAstraZeneca; Fondation ARCActive, not recruiting
-
Merck Sharp & Dohme LLCRecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Hepatocellular Carcinoma | Esophageal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder NeoplasmsUnited States, Chile, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Spain, Taiwan, Turkey, Canada
-
Hoffmann-La RocheRecruitingNon-Small Cell Lung CancerCanada, Belgium, Korea, Republic of, United States, France, Brazil, China, New Zealand, Israel, Spain, Argentina, Serbia, Mexico, Italy, Japan, Turkey, Taiwan, Costa Rica, Thailand, Australia, Germany, Hong Kong, Netherlands, Peru, Poland, Russian Federation and more
-
GlaxoSmithKlineMerck Sharp & Dohme LLCCompletedNeoplasmsUnited States, Australia, Spain, Italy, Japan, Netherlands, Canada, France, China
-
IGM Biosciences, Inc.RecruitingSarcoma | Acute Myeloid Leukemia | Colorectal Cancer | Solid Tumor | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chondrosarcoma | Small Lymphocytic LymphomaUnited States, Korea, Republic of, France, Spain, Australia
-
Ludwig Institute for Cancer ResearchAstraZenecaCompletedEsophageal CancerUnited Kingdom
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
Hoffmann-La RocheCompletedHER2-Positive Metastatic Breast Cancer | HER2-Negative Metastatic Breast Cancer | Locally Advanced or Early Breast CancerUnited States
-
Drexel University College of MedicineCompletedHead and Neck CancerUnited States
-
Hoffmann-La RocheActive, not recruiting
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | HER2-Negative Breast CarcinomaUnited States
-
Karolinska University HospitalRecruiting
-
Prof. W. JanniRoche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbHRecruiting
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Regione LombardiaActive, not recruitingUnresectable Sinonasal TumorsItaly
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Regione LombardiaActive, not recruitingSinonasal TumorsItaly
-
Hoffmann-La RocheNorwegian Radium HospitalCompleted
-
John P. FruehaufSanofiWithdrawnProstate Cancer | Stage I Prostate Cancer | Stage II Prostate Cancer | Adenocarcinoma of the Prostate
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
Spanish Breast Cancer Research GroupEli Lilly and CompanyActive, not recruiting
-
Cancer Trials IrelandSouthampton Clinical Trials Unit; Region H Rigshospitalet; Centre Hospitalier...CompletedOesophageal Cancer | Adenocarcinoma of the Oesophagus | Adenocarcinoma of the Oesophago-gastric Junction | Oesophageal Tumours | Junctional TumoursIreland, United Kingdom, Denmark, France, Sweden
-
AstraZenecaCompletedAdvanced Solid TumorUnited States
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Belgium, United Kingdom, Germany, Russian Federation, Italy, France
-
Sungkyunkwan UniversityMinistry of Food and Drug Safety, KoreaUnknownCarcinoma, Non-Small-Cell Lung | Immune-Related Adverse Events
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Sarcoma | Uterine Corpus LeiomyosarcomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedOvarian Clear Cell Cystadenocarcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States, Korea, Republic of, Japan
-
Washington University School of MedicineGenentech, Inc.Terminated
-
George Albert FisherSanofi; GlaxoSmithKlineCompletedBreast Cancer | Metastatic Breast CancerUnited States
-
Jilin UniversityUnknownAntineoplastic Combined Chemotherapy ProtocolsChina
-
National Institute of Oncology, HungaryNot yet recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IA...United States
-
The Methodist Hospital Research InstituteCompletedMetastatic Triple Negative Breast CancerUnited States
-
Medical Research CouncilActive, not recruitingProstate CancerUnited Kingdom, Switzerland
-
University of WashingtonNational Cancer Institute (NCI)CompletedHead and Neck Squamous Cell CarcinomaUnited States
-
University of WashingtonActive, not recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Castration-Resistant Prostate Carcinoma | Homologous Recombination Deficiency | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | ATM Gene Mutation | Prostate Carcinoma Metastatic in the Bone | PSA Level Greater...United States
-
M.D. Anderson Cancer CenterAstraZenecaRecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Hoffmann-La RocheRecruitingCarcinoma, Non-Small-Cell LungKorea, Republic of, France, Spain, Taiwan, United States, Israel, Australia, United Kingdom
-
Presage BiosciencesNorthwell Health; Oregon Health and Science University; University of Washington and other collaboratorsCompletedSoft Tissue Sarcoma AdultUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedProstate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIB Gastroesophageal... and other conditionsUnited States
-
Centro Nacional de Investigaciones Oncologicas...Apices Soluciones S.L.; Hospital Universitario de Fuenlabrada; Grupo Hospital...CompletedMetastatic Disease | Adenocarcinoma of Rectum | Adenocarcinoma of ColonSpain
-
Cancer Research AntwerpBayer; Veracyte, Inc.Recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Locally Advanced Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III... and other conditionsUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
Mayo ClinicNational Cancer Institute (NCI)CompletedThyroid Gland Undifferentiated (Anaplastic) CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage III Laryngeal Cancer AJCC v8 | Laryngeal Squamous Cell Carcinoma | Stage II Laryngeal Cancer AJCC v8United States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingStage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7 | Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7United States